Maravai LifeSciences Holdings, Inc. MRVI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $204.73M+10.2% | $185.74M-3.5% | $192.44M-12.5% | $219.83M-9.1% | $241.86M-6.7% | ||
| $144.76M-4.6% | $151.75M-0.1% | $151.9M-0.5% | $152.71M+0.7% | $151.67M+0.5% | ||
| $59.97M+76.4% | $33.99M-16.2% | $40.54M-39.6% | $67.12M-25.6% | $90.19M-16.7% | ||
| 29.3%+11.0pp | 18.3%-2.8pp | 21.1%-9.5pp | 30.5%-6.8pp | 37.3%-4.5pp | ||
| $16.4M-5.7% | $17.4M-4.3% | $18.18M-4.5% | $19.04M-0.2% | $19.08M-0.7% | ||
| $134.65M-7.2% | $145.12M-6.2% | $154.78M-2.3% | $158.47M-1.2% | $160.45M-0.8% | ||
| $267.86M-7.3% | $288.89M+5.3% | $274.34M-35.5% | $425.5M+7.8% | $394.69M-6.2% | ||
| -$168.26M+21.8% | -$215.27M-10.9% | -$194.17M+39.1% | -$318.76M-19.9% | -$265.92M-12.9% | ||
| -82.2%+33.7pp | -115.9%-15.0pp | -100.9%+44.1pp | -145%-35.1pp | -109.9%-19.0pp | ||
| $25.96M-3.8% | $26.99M-14.9% | $31.7M-17.6% | $38.49M-11.7% | $43.61M-8.6% | ||
| -$4.67M-12.5% | -$4.15M-1.0% | -$4.11M-3.6% | -$3.97M-60.8% | -$2.47M-3.4% | ||
| -$188.81M+19.6% | -$234.97M-7.8% | -$218.04M+36.8% | -$345.03M-18.3% | -$291.76M-11.6% | ||
| -$4.53M-7.4% | -$4.22M+0.2% | -$4.23M-10.5% | -$3.82M-94.1% | -$1.97M-5.9% | ||
| -$104.56M+20.0% | -$130.77M-8.1% | -$121M+37.1% | -$192.52M-18.3% | -$162.71M-12.3% | ||
| -51.1%+19.3pp | -70.4%-7.5pp | -62.9%+24.7pp | -87.6%-20.3pp | -67.3%-11.4pp | ||
| -$0.71+21.1% | -$0.90-7.1% | -$0.84+37.3% | -$1.34-17.5% | -$1.14-11.8% | ||
| -$118.1M+27.9% | -$163.76M-14.7% | -$142.74M+46.9% | -$268.57M-24.1% | -$216.47M-15.6% | ||
| -57.7%+30.5pp | -88.2%-14.0pp | -74.2%+48.0pp | -122.2%-32.7pp | -89.5%-17.3pp | ||
| -$168.26M+21.8% | -$215.27M-10.9% | -$194.17M+39.1% | -$318.76M-19.9% | -$265.92M-12.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated $204.7M in revenue over the trailing twelve months, down 15.3% year over year.
- Is Maravai LifeSciences Holdings, Inc. profitable?
- Maravai LifeSciences Holdings, Inc. is not currently profitable: it reported a net loss of $104.6M over the trailing twelve months, a -51.1% net margin.
- What are Maravai LifeSciences Holdings, Inc.'s profit margins?
- Gross margin is 29.3% and operating margin is -82.2%, with a -51.1% net margin.
- What is Maravai LifeSciences Holdings, Inc.'s earnings per share?
- Maravai LifeSciences Holdings, Inc.'s diluted EPS over the trailing twelve months is $-0.71.
- Where does Maravai LifeSciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
